TriMas Reports Fourth Quarter and Full Year 2025 Results
- Full‑year and fourth quarter 2025 results in line with Company expectations
- Repurchased more than three million shares during fourth quarter; today announced an increase in share repurchase authorization
-
Implemented cost reduction initiatives expected to generate
$15 million in annualized savings - Aerospace moved to Discontinued Operations; divestiture on track to close in first quarter 2026
|
Summary |
|||||||||||||||
|
($ in millions, except per share amounts) |
|||||||||||||||
|
|
|||||||||||||||
|
|
|
Twelve months ended |
|||||||||||||
|
|
|
As Reported |
|
Adjusted(1,2) |
|||||||||||
|
|
|
|
2025 |
|
2024 |
|
% Change |
|
|
2025 |
|
2024 |
% Change |
||
|
|
|
|
|
|
|
|
|
|
|||||||
|
Net sales |
|
|
|
|
|
|
|
|
|||||||
|
TriMas Continuing Operations |
|
$ |
645.7 |
$ |
630.8 |
|
2.4 |
% |
|
$ |
645.7 |
$ |
630.8 |
2.4 |
% |
|
Aerospace - Discontinued Operations |
|
|
396.4 |
|
294.2 |
|
34.7 |
% |
|
|
396.4 |
|
294.2 |
34.7 |
% |
|
|
|
$ |
1,042.2 |
$ |
925.0 |
|
12.7 |
% |
|
$ |
1,042.2 |
$ |
925.0 |
12.7 |
% |
|
|
|
|
|
|
|
|
|
|
|||||||
|
Operating profit |
|
|
|
|
|
|
|
|
|||||||
|
TriMas Continuing Operations |
|
$ |
41.3 |
$ |
15.2 |
|
172.2 |
% |
|
$ |
34.4 |
$ |
47.0 |
(26.9 |
)% |
|
Aerospace - Discontinued Operations |
|
|
67.0 |
$ |
32.0 |
|
109.2 |
% |
|
|
72.3 |
|
35.9 |
101.8 |
% |
|
|
|
$ |
108.3 |
$ |
47.2 |
|
129.5 |
% |
|
$ |
106.7 |
$ |
82.8 |
28.8 |
% |
|
|
|
|
|
|
|
|
|
|
|||||||
|
Income (loss) |
|
|
|
|
|
|
|
|
|||||||
|
TriMas Continuing Operations |
|
$ |
72.3 |
$ |
(2.0 |
) |
n/m |
|
|
$ |
22.4 |
$ |
31.6 |
(29.1 |
)% |
|
Aerospace - Discontinued Operations |
|
|
47.8 |
|
26.2 |
|
82.6 |
% |
|
|
62.8 |
|
36.1 |
73.9 |
% |
|
|
|
$ |
120.1 |
$ |
24.3 |
|
395.4 |
% |
|
$ |
85.3 |
$ |
67.7 |
25.9 |
% |
|
|
|
|
|
|
|
|
|
|
|||||||
|
Diluted earnings per share |
|
|
|
|
|
|
|
|
|||||||
|
TriMas Continuing Operations |
|
$ |
1.78 |
$ |
(0.05 |
) |
n/m |
|
|
$ |
0.55 |
$ |
0.77 |
(28.6 |
)% |
|
Aerospace - Discontinued Operations |
|
|
1.17 |
$ |
0.65 |
|
80.0 |
% |
|
$ |
1.54 |
$ |
0.88 |
75.0 |
% |
|
|
|
$ |
2.95 |
$ |
0.60 |
|
391.7 |
% |
|
$ |
2.09 |
$ |
1.65 |
26.7 |
% |
"We finished 2025 with a solid performance at the upper end of our earnings per share guidance range, supported by continued strong top-line growth and disciplined execution across our businesses,” said
Total Company Results (Before Consideration of Discontinued Operations)
TriMas reported full year 2025 total company net sales of
For fourth quarter 2025, total company net sales were
TriMas Aerospace Divestiture Update and Discontinued Operations
The previously announced sale of
Beginning in the fourth quarter of 2025, the Company began reporting the quarterly and full year results of
To provide historical information on a basis that reflects the planned sale of
Results from Continuing Operations
For full year 2025, TriMas reported net sales from continuing operations of
For fourth quarter 2025, TriMas reported fourth quarter 2025 net sales from continuing operations of
Share Repurchases
During 2025, TriMas repurchased 3,124,866 shares of its outstanding common stock for
Today, the Company announced that its Board of Directors has increased its common stock share repurchase authorization to a total of up to
Financial Position
The Company generated
TriMas ended 2025 with
Fourth Quarter Segment Results
TriMas' Specialty Products group reported fourth quarter net sales of
Realignment and Cost-Out Initiatives
TriMas executed a comprehensive organizational realignment to streamline operations, strengthen customer responsiveness and drive sustainable cost savings. The realignment integrates select corporate and business functions to simplify the structure, eliminates duplication and improves operational efficiency. These initiatives are expected to generate more than
As part of this effort,
2026 Outlook
For 2026, the Company expects sales growth of 3% to 6% year-over-year across the combined Packaging and Specialty Products businesses. In addition, TriMas anticipates more than 300 basis points of adjusted operating profit margin improvement, driven by the cost reduction and organizational realignment initiatives underway. Additional assumptions and modeling considerations will be discussed on the earnings call later this morning.
"As we prepare to complete the sale of
Conference Call Information
TriMas will host its fourth quarter and full year 2025 earnings conference call today,
Notice Regarding Forward-Looking Statements
The above outlook includes the impact of all announced acquisitions and divestitures as of
Any "forward-looking" statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, contained herein, including those relating to TriMas’ business, financial condition or future results, involve risks and uncertainties with respect to, including, but not limited to: general economic and currency conditions; competitive factors; market demand; our ability to realize our business strategies; government and regulatory actions, including, without limitation, the impact of current and future tariffs and reciprocal tariffs, quotas and surcharges, as well as climate change legislation and other environmental regulations; our ability to identify attractive acquisition candidates, successfully integrate acquired operations or realize the intended benefits of such acquisitions; our ability to successfully complete the planned sale of our
Non-GAAP Financial Measures
In this release, certain non-GAAP financial measures are used. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measure may be found in Appendix I at the end of this release. Management believes that presenting these non-GAAP financial measures provides useful information to investors by helping them identify underlying trends in the Company’s businesses and facilitating comparisons of performance with prior and future periods and to the Company’s peers. These non-GAAP financial measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
Reconciliations of forward-looking non-GAAP financial measures to the most directly comparable GAAP financial measures are provided only for the expected impact of amortization of acquisition-related intangible assets for completed acquisitions, as the Company is unable to provide estimates of future Special Items(1) or amortization from future acquisitions without unreasonable effort, due to the uncertainty and inherent difficulty of predicting the occurrence and the financial impact of such items impacting comparability and the periods in which such items may be recognized. For the same reasons, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.
Additional information is available at www.trimas.com under the “Investors” section.
|
(1) |
Appendix I details certain costs, expenses and other amounts or charges, collectively described as "Special Items," that are included in the determination of net income, earnings per share and/or cash flows from operating activities under GAAP, but that management believes should be separately considered when evaluating the quality of the Company’s core operating results, given they may not reflect the ongoing activities of the business. |
|
|
(2) |
The Company defines adjusted net income (and on a per diluted share basis, adjusted diluted earnings per share) as net income (per GAAP), plus or minus the after-tax impact of Special Items(1), plus the after-tax impacts of non-cash acquisition-related intangible asset amortization and non-cash compensation expense. While the acquisition-related intangible assets aid in the Company’s revenue generation, the Company adjusts for the non-cash amortization expense and non-cash compensation expense because the Company believes it (i) enhances management’s and investors’ ability to analyze underlying business performance, (ii) facilitates comparisons of financial results over multiple periods, and (iii) provides more relevant comparisons of financial results with the results of other companies as the amortization expense associated with these assets may fluctuate significantly from period to period based on the timing, size, nature, and number of acquisitions. |
|
|
(3) |
The Company defines Free Cash Flow as Net Cash Provided by/Used for Operating Activities, excluding the cash impact of Special Items, less Capital Expenditures. Please see Appendix I for additional details. |
|
|
(4) |
The Company defines Net Debt as Total Debt less Cash and Cash Equivalents. Please see Appendix I for additional details. |
About TriMas
TriMas designs and manufactures a diverse set of products primarily for the consumer products, aerospace and industrial markets through its
|
Condensed Consolidated Balance Sheet (Unaudited, dollars in thousands) |
||||||
|
|
||||||
|
|
|
|
|
|
||
|
Assets |
|
|
|
|
||
|
Current assets: |
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
30,020 |
|
$ |
23,070 |
|
Receivables, net |
|
|
111,270 |
|
|
115,590 |
|
Inventories |
|
|
108,720 |
|
|
110,440 |
|
Prepaid expenses and other current assets |
|
|
36,380 |
|
|
27,260 |
|
Current assets, held for sale |
|
|
176,280 |
|
|
150,280 |
|
Total current assets |
|
|
462,670 |
|
|
426,640 |
|
Property and equipment, net |
|
|
247,510 |
|
|
237,700 |
|
Operating lease right-of-use assets |
|
|
31,800 |
|
|
32,440 |
|
|
|
|
300,280 |
|
|
287,060 |
|
Other intangibles, net |
|
|
76,550 |
|
|
78,390 |
|
Deferred income taxes |
|
|
53,670 |
|
|
10,760 |
|
Other assets |
|
|
45,430 |
|
|
9,410 |
|
Non-current assets, held for sale |
|
|
267,170 |
|
|
241,780 |
|
Total assets |
|
$ |
1,485,080 |
|
$ |
1,324,180 |
|
Liabilities and Shareholders' Equity |
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
||
|
Accounts payable |
|
$ |
72,280 |
|
$ |
72,350 |
|
Accrued liabilities |
|
|
59,640 |
|
|
42,760 |
|
Lease liabilities, current portion |
|
|
4,100 |
|
|
6,000 |
|
Current liabilities, held for sale |
|
|
47,650 |
|
|
38,320 |
|
Total current liabilities |
|
|
183,670 |
|
|
159,430 |
|
Long-term debt, net |
|
|
469,170 |
|
|
398,120 |
|
Lease liabilities |
|
|
31,810 |
|
|
30,240 |
|
Deferred income taxes |
|
|
17,710 |
|
|
17,580 |
|
Other long-term liabilities |
|
|
65,840 |
|
|
42,170 |
|
Non-current liabilities, held for sale |
|
|
11,290 |
|
|
9,340 |
|
Total liabilities |
|
|
779,490 |
|
|
656,880 |
|
Total shareholders' equity |
|
|
705,590 |
|
|
667,300 |
|
Total liabilities and shareholders' equity |
|
$ |
1,485,080 |
|
$ |
1,324,180 |
|
Consolidated Statement of Income (Unaudited, dollars in thousands, except share and per share amounts) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
||||||||||
|
Net sales |
|
$ |
155,490 |
|
|
$ |
149,730 |
|
|
$ |
645,720 |
|
|
$ |
630,800 |
|
|
Cost of sales |
|
|
(122,580 |
) |
|
|
(127,270 |
) |
|
|
(507,560 |
) |
|
|
(501,260 |
) |
|
Gross profit |
|
|
32,910 |
|
|
|
22,460 |
|
|
|
138,160 |
|
|
|
129,540 |
|
|
Selling, general and administrative expenses |
|
|
(38,160 |
) |
|
|
(23,020 |
) |
|
|
(129,310 |
) |
|
|
(109,650 |
) |
|
Asbestos-related benefit (costs), net |
|
|
35,800 |
|
|
|
— |
|
|
|
27,770 |
|
|
|
(5,510 |
) |
|
Net gain (loss) on dispositions of assets |
|
|
(610 |
) |
|
|
(10 |
) |
|
|
4,680 |
|
|
|
1,020 |
|
|
Impairment of indefinite-lived intangible assets |
|
|
— |
|
|
|
(230 |
) |
|
|
— |
|
|
|
(230 |
) |
|
Operating profit (loss) |
|
|
29,940 |
|
|
|
(800 |
) |
|
|
41,300 |
|
|
|
15,170 |
|
|
Other expense, net: |
|
|
|
|
|
|
|
|
||||||||
|
Interest expense |
|
|
(4,590 |
) |
|
|
(4,550 |
) |
|
|
(18,030 |
) |
|
|
(19,560 |
) |
|
Other income (expense), net |
|
|
(320 |
) |
|
|
540 |
|
|
|
990 |
|
|
|
210 |
|
|
Other expense, net |
|
|
(4,910 |
) |
|
|
(4,010 |
) |
|
|
(17,040 |
) |
|
|
(19,350 |
) |
|
Income (loss) before income tax expense |
|
|
25,030 |
|
|
|
(4,810 |
) |
|
|
24,260 |
|
|
|
(4,180 |
) |
|
Income tax benefit |
|
|
47,820 |
|
|
|
1,290 |
|
|
|
48,050 |
|
|
|
2,230 |
|
|
Income (loss) from continuing operations |
|
|
72,850 |
|
|
|
(3,520 |
) |
|
|
72,310 |
|
|
|
(1,950 |
) |
|
Income from discontinued operations, net of income taxes |
|
|
8,850 |
|
|
|
9,160 |
|
|
|
47,830 |
|
|
|
26,200 |
|
|
Net income |
|
$ |
81,700 |
|
|
$ |
5,640 |
|
|
$ |
120,140 |
|
|
$ |
24,250 |
|
|
Basic earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
|
Continuing operations |
|
$ |
1.84 |
|
|
$ |
(0.09 |
) |
|
$ |
1.79 |
|
|
$ |
(0.05 |
) |
|
Discontinued operations |
|
|
0.22 |
|
|
|
0.23 |
|
|
|
1.18 |
|
|
|
0.65 |
|
|
Net income per share |
|
$ |
2.06 |
|
|
$ |
0.14 |
|
|
$ |
2.97 |
|
|
$ |
0.60 |
|
|
Weighted average common shares - basic |
|
|
39,633,498 |
|
|
|
40,573,108 |
|
|
|
40,384,270 |
|
|
|
40,725,714 |
|
|
Diluted earnings (loss) per share: |
|
|
|
|
|
|
|
|
||||||||
|
Continuing operations |
|
$ |
1.81 |
|
|
$ |
(0.09 |
) |
|
$ |
1.78 |
|
|
$ |
(0.05 |
) |
|
Discontinued operations |
|
|
0.22 |
|
|
|
0.23 |
|
|
|
1.17 |
|
|
|
0.65 |
|
|
Net income per share |
|
$ |
2.03 |
|
|
$ |
0.14 |
|
|
$ |
2.95 |
|
|
$ |
0.60 |
|
|
Weighted average common shares - diluted |
|
|
40,148,066 |
|
|
|
40,573,108 |
|
|
|
40,790,137 |
|
|
|
40,725,714 |
|
|
Consolidated Statement of Cash Flows (Unaudited - dollars in thousands) |
||||||||
|
|
||||||||
|
|
|
Twelve months ended
|
||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
Cash Flows from Operating Activities: |
|
|
|
|
||||
|
Income (loss) from continuing operations |
|
$ |
72,310 |
|
|
$ |
(1,950 |
) |
|
Income from discontinued operations |
|
|
47,830 |
|
|
|
26,200 |
|
|
Net income |
|
|
120,140 |
|
|
|
24,250 |
|
|
Adjustments to reconcile income to net cash provided by operating activities, net of acquisition impact: |
|
|
|
|
||||
|
Impairment of indefinite-lived intangible assets |
|
|
— |
|
|
|
230 |
|
|
Gain on dispositions of assets |
|
|
(4,510 |
) |
|
|
(1,000 |
) |
|
Depreciation |
|
|
39,710 |
|
|
|
48,120 |
|
|
Amortization of intangible assets |
|
|
17,320 |
|
|
|
16,800 |
|
|
Amortization of debt issue costs |
|
|
950 |
|
|
|
960 |
|
|
Deferred income taxes |
|
|
(37,390 |
) |
|
|
(3,240 |
) |
|
Non-cash compensation expense |
|
|
11,540 |
|
|
|
6,960 |
|
|
Provision for losses on accounts receivable |
|
|
(1,250 |
) |
|
|
(1,000 |
) |
|
Asbestos-related (benefit) costs, net |
|
|
(27,770 |
) |
|
|
5,510 |
|
|
Provision for environmental liabilities |
|
|
6,500 |
|
|
|
3,340 |
|
|
(Increase) decrease in receivables |
|
|
1,780 |
|
|
|
(20,520 |
) |
|
Increase in inventories |
|
|
(4,270 |
) |
|
|
(21,200 |
) |
|
(Increase) decrease in prepaid expenses and other assets |
|
|
4,050 |
|
|
|
(2,340 |
) |
|
Increase (decrease) in accounts payable and accrued liabilities |
|
|
(2,360 |
) |
|
|
560 |
|
|
Other operating activities |
|
|
(6,990 |
) |
|
|
6,350 |
|
|
Net cash provided by operating activities |
|
|
117,450 |
|
|
|
63,780 |
|
|
Cash Flows from Investing Activities: |
|
|
|
|
||||
|
Capital expenditures |
|
|
(48,350 |
) |
|
|
(50,960 |
) |
|
Acquisition of businesses, net of cash acquired |
|
|
(37,730 |
) |
|
|
— |
|
|
Cross-currency swap terminations |
|
|
— |
|
|
|
(3,760 |
) |
|
Settlement of foreign currency exchange forward contract |
|
|
— |
|
|
|
3,760 |
|
|
Net proceeds from disposition of business, property and equipment |
|
|
22,030 |
|
|
|
4,000 |
|
|
Net cash used for investing activities |
|
|
(64,050 |
) |
|
|
(46,960 |
) |
|
Cash Flows from Financing Activities: |
|
|
|
|
||||
|
Proceeds from borrowings on revolving credit facilities |
|
|
356,300 |
|
|
|
308,930 |
|
|
Repayments of borrowings on revolving credit facilities |
|
|
(289,850 |
) |
|
|
(307,580 |
) |
|
Debt financing fees |
|
|
(1,260 |
) |
|
|
— |
|
|
Payments to purchase common stock |
|
|
(103,320 |
) |
|
|
(19,270 |
) |
|
Shares surrendered upon exercise and vesting of equity awards to cover taxes |
|
|
(2,000 |
) |
|
|
(1,760 |
) |
|
Dividends paid |
|
|
(6,610 |
) |
|
|
(6,630 |
) |
|
Other financing activities |
|
|
290 |
|
|
|
(2,330 |
) |
|
Net cash used for financing activities |
|
|
(46,450 |
) |
|
|
(28,640 |
) |
|
Cash and Cash Equivalents: |
|
|
|
|
||||
|
Increase (decrease) for the year |
|
|
6,950 |
|
|
|
(11,820 |
) |
|
At beginning of year |
|
|
23,070 |
|
|
|
34,890 |
|
|
At end of year |
|
$ |
30,020 |
|
|
$ |
23,070 |
|
|
Supplemental disclosure of cash flow information: |
|
|
|
|
||||
|
Cash paid for interest |
|
$ |
18,760 |
|
|
$ |
18,730 |
|
|
Cash paid for income taxes |
|
$ |
10,630 |
|
|
$ |
11,870 |
|
|
Non-cash property additions |
|
$ |
5,170 |
|
|
$ |
— |
|
Appendix I
|
Additional Information Regarding Special Items Impacting Reported GAAP Financial Measures (Unaudited - dollars in thousands) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Packaging |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
129,260 |
|
|
$ |
123,130 |
|
|
$ |
535,540 |
|
|
$ |
512,320 |
|
|
Operating profit |
|
$ |
14,620 |
|
|
$ |
15,060 |
|
|
$ |
68,140 |
|
|
$ |
68,120 |
|
|
Special Items to consider in evaluating operating profit: |
|
|
|
|
|
|
|
|
||||||||
|
Impairment of and indefinite-lived intangible assets |
|
|
— |
|
|
|
230 |
|
|
|
— |
|
|
|
230 |
|
|
Business restructuring and severance costs |
|
|
350 |
|
|
|
450 |
|
|
|
3,270 |
|
|
|
2,870 |
|
|
Adjusted operating profit |
|
$ |
14,970 |
|
|
$ |
15,740 |
|
|
$ |
71,410 |
|
|
$ |
71,220 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Specialty Products |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
26,230 |
|
|
$ |
26,600 |
|
|
$ |
110,180 |
|
|
$ |
118,480 |
|
|
Operating profit (loss) |
|
$ |
1,710 |
|
|
$ |
(7,470 |
) |
|
$ |
4,190 |
|
|
$ |
(1,990 |
) |
|
Special Items to consider in evaluating operating profit: |
|
|
|
|
|
|
|
|
||||||||
|
Business restructuring and severance costs |
|
|
— |
|
|
|
8,230 |
|
|
|
1,240 |
|
|
|
8,350 |
|
|
Adjusted operating profit |
|
$ |
1,710 |
|
|
$ |
760 |
|
|
$ |
5,430 |
|
|
$ |
6,360 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Corporate Expenses |
|
|
|
|
|
|
|
|
||||||||
|
Operating profit (loss) |
|
$ |
13,610 |
|
|
$ |
(8,390 |
) |
|
$ |
(31,030 |
) |
|
$ |
(50,960 |
) |
|
Special Items to consider in evaluating operating loss: |
|
|
|
|
|
|
|
|
||||||||
|
Asbestos-related (benefit) costs, net |
|
|
(35,800 |
) |
|
|
— |
|
|
|
(27,770 |
) |
|
|
5,510 |
|
|
Change in environmental liability estimate |
|
|
6,500 |
|
|
|
960 |
|
|
|
6,500 |
|
|
|
3,220 |
|
|
M&A diligence and transaction costs |
|
|
240 |
|
|
|
430 |
|
|
|
630 |
|
|
|
3,450 |
|
|
Business restructuring and severance costs |
|
|
780 |
|
|
|
1,940 |
|
|
|
8,280 |
|
|
|
3,450 |
|
|
System implementation costs |
|
|
1,980 |
|
|
|
1,120 |
|
|
|
6,280 |
|
|
|
4,740 |
|
|
Gain on sale of |
|
|
— |
|
|
|
— |
|
|
|
(5,380 |
) |
|
|
— |
|
|
Adjusted operating loss |
|
$ |
(12,690 |
) |
|
$ |
(3,940 |
) |
|
$ |
(42,490 |
) |
|
$ |
(30,590 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||
|
TriMas Continuing Operations |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
155,490 |
|
|
$ |
149,730 |
|
|
$ |
645,720 |
|
|
$ |
630,800 |
|
|
Operating profit (loss) |
|
$ |
29,940 |
|
|
$ |
(800 |
) |
|
$ |
41,300 |
|
|
$ |
15,170 |
|
|
Total Special Items to consider in evaluating operating profit |
|
|
(25,950 |
) |
|
|
13,360 |
|
|
|
(6,950 |
) |
|
|
31,820 |
|
|
Adjusted operating profit |
|
$ |
3,990 |
|
|
$ |
12,560 |
|
|
$ |
34,350 |
|
|
$ |
46,990 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Aerospace |
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
100,970 |
|
|
$ |
78,320 |
|
|
$ |
396,430 |
|
|
$ |
294,210 |
|
|
Operating profit |
|
$ |
12,860 |
|
|
$ |
9,420 |
|
|
$ |
67,000 |
|
|
$ |
32,020 |
|
|
Special Items to consider in evaluating operating profit: |
|
|
|
|
|
|
|
|
||||||||
|
Third-party and other costs incurred related to strike |
|
|
— |
|
|
|
1,050 |
|
|
|
— |
|
|
|
3,390 |
|
|
M&A diligence and transaction costs |
|
|
3,080 |
|
|
|
— |
|
|
|
3,080 |
|
|
|
60 |
|
|
Business restructuring and severance costs |
|
|
(110 |
) |
|
|
— |
|
|
|
710 |
|
|
|
— |
|
|
Change in environmental liability estimate |
|
|
— |
|
|
|
150 |
|
|
|
— |
|
|
|
380 |
|
|
Purchase accounting costs |
|
|
350 |
|
|
|
— |
|
|
|
1,550 |
|
|
|
— |
|
|
Adjusted operating profit |
|
$ |
16,180 |
|
|
$ |
10,620 |
|
|
$ |
72,340 |
|
|
$ |
35,850 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net sales |
|
$ |
256,460 |
|
|
$ |
228,050 |
|
|
$ |
1,042,150 |
|
|
$ |
925,010 |
|
|
Operating profit |
|
$ |
42,800 |
|
|
$ |
8,620 |
|
|
$ |
108,300 |
|
|
$ |
47,190 |
|
|
Total Special Items to consider in evaluating operating profit |
|
|
(22,630 |
) |
|
|
14,560 |
|
|
|
(1,610 |
) |
|
|
35,650 |
|
|
Adjusted operating profit |
|
$ |
20,170 |
|
|
$ |
23,180 |
|
|
$ |
106,690 |
|
|
$ |
82,840 |
|
Appendix I
|
Additional Information Regarding Special Items Impacting
Reported GAAP Financial Measures - (Unaudited - dollars in thousands, except share and per share amounts) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Net income, |
|
$ |
81,700 |
|
|
$ |
5,640 |
|
|
$ |
120,140 |
|
|
$ |
24,250 |
|
|
Special Items to consider in evaluating quality of net income: |
|
|
|
|
|
|
|
|
||||||||
|
Asbestos-related (benefit) costs, net |
|
|
(35,800 |
) |
|
|
— |
|
|
|
(27,770 |
) |
|
|
5,510 |
|
|
Business restructuring and severance costs |
|
|
1,020 |
|
|
|
10,620 |
|
|
|
13,500 |
|
|
|
14,670 |
|
|
M&A diligence and transaction costs |
|
|
3,320 |
|
|
|
430 |
|
|
|
3,710 |
|
|
|
3,510 |
|
|
System implementation costs |
|
|
1,980 |
|
|
|
1,120 |
|
|
|
6,280 |
|
|
|
4,740 |
|
|
Third-party and other costs incurred related to strike |
|
|
— |
|
|
|
1,050 |
|
|
|
— |
|
|
|
3,390 |
|
|
Change in environmental liability estimate |
|
|
6,500 |
|
|
|
1,110 |
|
|
|
6,500 |
|
|
|
3,600 |
|
|
Reversal of a contingent deferred purchase price liability |
|
|
— |
|
|
|
(2,250 |
) |
|
|
— |
|
|
|
(2,250 |
) |
|
Currency translation adjustment |
|
|
(1,540 |
) |
|
|
— |
|
|
|
(1,540 |
) |
|
|
— |
|
|
Gain on the sale of |
|
|
— |
|
|
|
— |
|
|
|
(5,380 |
) |
|
|
— |
|
|
Deferred tax gain on the sale of Aerospace segment |
|
|
(53,900 |
) |
|
|
— |
|
|
|
(53,900 |
) |
|
|
— |
|
|
Purchase accounting costs and other |
|
|
350 |
|
|
|
230 |
|
|
|
1,650 |
|
|
|
240 |
|
|
Amortization of acquisition-related intangible assets |
|
|
4,380 |
|
|
|
4,160 |
|
|
|
17,320 |
|
|
|
16,800 |
|
|
Non-cash compensation expense |
|
|
3,240 |
|
|
|
(1,090 |
) |
|
|
10,040 |
|
|
|
6,960 |
|
|
Income tax effect of net income adjustments(1) |
|
|
5,000 |
|
|
|
(3,500 |
) |
|
|
(5,300 |
) |
|
|
(13,690 |
) |
|
Adjusted net income |
|
$ |
16,250 |
|
|
$ |
17,520 |
|
|
$ |
85,250 |
|
|
$ |
67,730 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Diluted earnings per share, |
|
$ |
2.03 |
|
|
$ |
0.14 |
|
|
$ |
2.95 |
|
|
$ |
0.60 |
|
|
Dilutive impact (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(0.01 |
) |
|
Special Items to consider in evaluating quality of EPS: |
|
|
|
|
|
|
|
|
||||||||
|
Asbestos-related (benefit) costs, net |
|
|
(0.89 |
) |
|
|
— |
|
|
|
(0.68 |
) |
|
|
0.13 |
|
|
Business restructuring and severance costs |
|
|
0.03 |
|
|
|
0.26 |
|
|
|
0.33 |
|
|
|
0.36 |
|
|
M&A diligence and transaction costs |
|
|
0.08 |
|
|
|
0.01 |
|
|
|
0.09 |
|
|
|
0.08 |
|
|
System implementation costs |
|
|
0.05 |
|
|
|
0.03 |
|
|
|
0.15 |
|
|
|
0.11 |
|
|
Third-party and other costs incurred related to strike |
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.08 |
|
|
Change in environmental liability estimate |
|
|
0.16 |
|
|
|
0.03 |
|
|
|
0.16 |
|
|
|
0.09 |
|
|
Reversal of a contingent deferred purchase price liability |
|
|
— |
|
|
|
(0.05 |
) |
|
|
— |
|
|
|
(0.05 |
) |
|
Currency translation adjustment |
|
|
(0.04 |
) |
|
|
— |
|
|
|
(0.04 |
) |
|
|
— |
|
|
Gain on the sale of |
|
|
— |
|
|
|
— |
|
|
|
(0.13 |
) |
|
|
— |
|
|
Deferred tax gain on the sale of Aerospace segment |
|
|
(1.34 |
) |
|
|
— |
|
|
|
(1.32 |
) |
|
|
— |
|
|
Purchase accounting costs and other |
|
|
0.01 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.01 |
|
|
Amortization of acquisition-related intangible assets |
|
|
0.11 |
|
|
|
0.10 |
|
|
|
0.42 |
|
|
|
0.41 |
|
|
Non-cash compensation expense |
|
|
0.08 |
|
|
|
(0.03 |
) |
|
|
0.25 |
|
|
|
0.17 |
|
|
Income tax effect of net income adjustments(1) |
|
|
0.12 |
|
|
|
(0.09 |
) |
|
|
(0.13 |
) |
|
|
(0.33 |
) |
|
Adjusted diluted EPS |
|
$ |
0.40 |
|
|
$ |
0.43 |
|
|
$ |
2.09 |
|
|
$ |
1.65 |
|
|
Weighted-average shares outstanding |
|
|
40,148,066 |
|
|
|
40,956,347 |
|
|
|
40,790,137 |
|
|
|
41,055,993 |
|
|
(1) |
Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the three and twelve month periods ended |
|
|
(2) |
330,279 shares were included in the as previously reported dilutive computation of earnings per share for the twelve months ended |
Appendix I
|
Additional Information Regarding Special Items Impacting Reported GAAP Financial Measures - Continuing Operations (Unaudited - dollars in thousands, except share and per share amounts) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Income (loss) from continuing operations, as reported |
|
$ |
72,850 |
|
|
$ |
(3,520 |
) |
|
$ |
72,310 |
|
|
$ |
(1,950 |
) |
|
Special Items to consider in evaluating quality of income: |
|
|
|
|
|
|
|
|
||||||||
|
Asbestos-related (benefit) costs, net |
|
|
(35,800 |
) |
|
|
— |
|
|
|
(27,770 |
) |
|
|
5,510 |
|
|
Business restructuring and severance costs |
|
|
1,130 |
|
|
|
10,620 |
|
|
|
12,790 |
|
|
|
14,670 |
|
|
M&A diligence and transaction costs |
|
|
(160 |
) |
|
|
430 |
|
|
|
(790 |
) |
|
|
3,450 |
|
|
System implementation costs |
|
|
1,980 |
|
|
|
1,120 |
|
|
|
6,280 |
|
|
|
4,740 |
|
|
Change in environmental liability estimate |
|
|
6,500 |
|
|
|
960 |
|
|
|
6,500 |
|
|
|
3,220 |
|
|
Currency translation adjustment |
|
|
(1,540 |
) |
|
|
— |
|
|
|
(1,540 |
) |
|
|
— |
|
|
Gain on the sale of |
|
|
— |
|
|
|
— |
|
|
|
(5,380 |
) |
|
|
— |
|
|
Deferred tax gain on the sale of Aerospace |
|
|
(53,900 |
) |
|
|
— |
|
|
|
(53,900 |
) |
|
|
— |
|
|
Other costs |
|
|
— |
|
|
|
230 |
|
|
|
100 |
|
|
|
240 |
|
|
Amortization of acquisition-related intangible assets |
|
|
1,700 |
|
|
|
1,590 |
|
|
|
6,680 |
|
|
|
6,520 |
|
|
Non-cash compensation expense |
|
|
2,870 |
|
|
|
(1,390 |
) |
|
|
8,410 |
|
|
|
5,630 |
|
|
Income tax effect of net income adjustments(1) |
|
|
5,990 |
|
|
|
(2,950 |
) |
|
|
(1,270 |
) |
|
|
(10,430 |
) |
|
Adjusted income from continuing operations |
|
$ |
1,620 |
|
|
$ |
7,090 |
|
|
$ |
22,420 |
|
|
$ |
31,600 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Diluted earnings (loss) per share from continuing operations, as reported |
|
$ |
1.81 |
|
|
$ |
(0.09 |
) |
|
$ |
1.78 |
|
|
$ |
(0.05 |
) |
|
Special Items to consider in evaluating quality of EPS from continuing operations: |
|
|
|
|
|
|
|
|
||||||||
|
Asbestos-related (benefit) costs, net |
|
|
(0.89 |
) |
|
|
— |
|
|
|
(0.68 |
) |
|
|
0.13 |
|
|
Business restructuring and severance costs |
|
|
0.03 |
|
|
|
0.26 |
|
|
|
0.31 |
|
|
|
0.36 |
|
|
M&A diligence and transaction costs |
|
|
— |
|
|
|
0.01 |
|
|
|
(0.02 |
) |
|
|
0.08 |
|
|
System implementation costs |
|
|
0.05 |
|
|
|
0.03 |
|
|
|
0.15 |
|
|
|
0.11 |
|
|
Change in environmental liability estimate |
|
|
0.16 |
|
|
|
0.02 |
|
|
|
0.16 |
|
|
|
0.08 |
|
|
Currency translation adjustment |
|
|
(0.04 |
) |
|
|
— |
|
|
|
(0.04 |
) |
|
|
— |
|
|
Gain on the sale of |
|
|
— |
|
|
|
— |
|
|
|
(0.13 |
) |
|
|
— |
|
|
Deferred tax gain on the sale of Aerospace |
|
|
(1.34 |
) |
|
|
— |
|
|
|
(1.32 |
) |
|
|
— |
|
|
Other costs |
|
|
— |
|
|
|
0.01 |
|
|
|
— |
|
|
|
0.01 |
|
|
Amortization of acquisition-related intangible assets |
|
|
0.04 |
|
|
|
0.03 |
|
|
|
0.16 |
|
|
|
0.16 |
|
|
Non-cash compensation expense |
|
|
0.07 |
|
|
|
(0.03 |
) |
|
|
0.21 |
|
|
|
0.14 |
|
|
Income tax effect of net income adjustments(1) |
|
|
0.15 |
|
|
|
(0.07 |
) |
|
|
(0.03 |
) |
|
|
(0.25 |
) |
|
Adjusted diluted EPS from continuing operations |
|
$ |
0.04 |
|
|
$ |
0.17 |
|
|
$ |
0.55 |
|
|
$ |
0.77 |
|
|
Weighted-average shares outstanding |
|
|
40,148,066 |
|
|
|
40,956,347 |
|
|
|
40,790,137 |
|
|
|
41,055,993 |
|
|
(1) |
Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the three and twelve month periods ended |
Appendix I
|
Additional Information Regarding Special Items Impacting Reported GAAP Financial Measures - Discontinued Operations (Unaudited - dollars in thousands, except share and per share amounts) |
||||||||||||||||
|
|
||||||||||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Income from discontinued operations, net of taxes |
|
$ |
8,850 |
|
|
$ |
9,160 |
|
|
$ |
47,830 |
|
|
$ |
26,200 |
|
|
Special Items to consider in evaluating quality of income: |
|
|
|
|
|
|
|
|
||||||||
|
Business restructuring and severance costs |
|
|
(110 |
) |
|
|
— |
|
|
|
710 |
|
|
|
— |
|
|
M&A diligence and transaction costs |
|
|
3,480 |
|
|
|
— |
|
|
|
4,500 |
|
|
|
60 |
|
|
Third-party and other costs incurred related to strike |
|
|
— |
|
|
|
1,050 |
|
|
|
— |
|
|
|
3,390 |
|
|
Change in environmental liability estimate |
|
|
— |
|
|
|
150 |
|
|
|
— |
|
|
|
380 |
|
|
Reversal of a contingent deferred purchase price liability |
|
|
— |
|
|
|
(2,250 |
) |
|
|
— |
|
|
|
(2,250 |
) |
|
Purchase accounting costs and other |
|
|
350 |
|
|
|
— |
|
|
|
1,550 |
|
|
|
— |
|
|
Amortization of acquisition-related intangible assets |
|
|
2,680 |
|
|
|
2,570 |
|
|
|
10,640 |
|
|
|
10,280 |
|
|
Non-cash compensation expense |
|
|
370 |
|
|
|
300 |
|
|
|
1,630 |
|
|
|
1,330 |
|
|
Income tax effect of net income adjustments(1) |
|
|
(990 |
) |
|
|
(550 |
) |
|
|
(4,030 |
) |
|
|
(3,260 |
) |
|
Adjusted income from discontinued operations, net of taxes |
|
$ |
14,630 |
|
|
$ |
10,430 |
|
|
$ |
62,830 |
|
|
$ |
36,130 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
Three months ended
|
|
Twelve months ended
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
Diluted earnings per share from discontinued operations |
|
$ |
0.22 |
|
|
$ |
0.23 |
|
|
$ |
1.17 |
|
|
$ |
0.65 |
|
|
Dilutive impact (2) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(0.01 |
) |
|
Special Items to consider in evaluating quality of EPS: |
|
|
|
|
|
|
|
|
||||||||
|
Business restructuring and severance costs |
|
|
— |
|
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
M&A diligence and transaction costs |
|
|
0.08 |
|
|
|
— |
|
|
|
0.11 |
|
|
|
— |
|
|
Third-party and other costs incurred related to strike |
|
|
— |
|
|
|
0.02 |
|
|
|
— |
|
|
|
0.08 |
|
|
Change in environmental liability estimate |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0.01 |
|
|
Reversal of a contingent deferred purchase price liability |
|
|
— |
|
|
|
(0.05 |
) |
|
|
— |
|
|
|
(0.05 |
) |
|
Purchase accounting costs and other |
|
|
0.01 |
|
|
|
— |
|
|
|
0.04 |
|
|
|
— |
|
|
Amortization of acquisition-related intangible assets |
|
|
0.07 |
|
|
|
0.07 |
|
|
|
0.26 |
|
|
|
0.25 |
|
|
Non-cash compensation expense |
|
|
0.01 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
|
0.03 |
|
|
Income tax effect of net income adjustments(1) |
|
|
(0.03 |
) |
|
|
(0.02 |
) |
|
|
(0.10 |
) |
|
|
(0.08 |
) |
|
Adjusted diluted EPS from discontinued operations |
|
$ |
0.36 |
|
|
$ |
0.26 |
|
|
$ |
1.54 |
|
|
$ |
0.88 |
|
|
Weighted-average shares outstanding |
|
|
40,148,066 |
|
|
|
40,956,347 |
|
|
|
40,790,137 |
|
|
|
41,055,993 |
|
|
(1) |
Income tax effect is calculated on an item-by-item basis, utilizing the statutory tax rate in the jurisdiction where the adjustments occurred. For the three and twelve month periods ended |
|
|
(2) |
330,279 shares were included in the as previously reported dilutive computation of earnings per share for the twelve months ended |
Appendix I
|
Additional Information Regarding Special Items Impacting
Reported GAAP Financial Measures - (Unaudited - dollars in thousands) |
||||||||||||||||||||||
|
|
||||||||||||||||||||||
|
|
Three months ended |
|||||||||||||||||||||
|
|
|
2025 |
|
2024 |
|
|||||||||||||||||
|
|
|
As
|
|
Special
|
|
As
|
|
As
|
|
Special
|
|
As
|
||||||||||
|
Net cash provided by operating activities |
|
$ |
41,520 |
|
|
$ |
6,520 |
|
$ |
48,040 |
|
$ |
27,080 |
|
|
$ |
4,650 |
|
$ |
31,730 |
|
|
|
Less: Capital expenditures |
|
|
(4,700 |
) |
|
|
— |
|
|
(4,700 |
) |
|
(14,980 |
) |
|
|
— |
|
|
(14,980 |
) |
|
|
Free Cash Flow |
|
$ |
36,820 |
|
|
$ |
6,520 |
|
$ |
43,340 |
|
$ |
12,100 |
|
|
$ |
4,650 |
|
$ |
16,750 |
|
|
|
|
|
|
|
|
||||||||||||||||||
|
|
Twelve months ended |
|||||||||||||||||||||
|
|
2025 |
|
|
2024 |
|
|||||||||||||||||
|
|
|
As
|
|
Special
|
|
As
|
|
As
|
|
Special
|
|
As
|
||||||||||
|
Net cash provided by operating activities |
|
$ |
117,450 |
|
|
$ |
18,130 |
|
$ |
135,580 |
|
|
|
63,780 |
|
|
$ |
16,490 |
|
$ |
80,270 |
|
|
Less: Capital expenditures |
|
|
(48,350 |
) |
|
|
— |
|
|
(48,350 |
) |
|
|
(50,960 |
) |
|
|
— |
|
|
(50,960 |
) |
|
Free Cash Flow |
|
$ |
69,100 |
|
|
$ |
18,130 |
|
$ |
87,230 |
|
|
$ |
12,820 |
|
|
$ |
16,490 |
|
$ |
29,310 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||
|
|
|
|
|
|
||
|
Long-term debt, net |
|
$ |
469,170 |
|
$ |
398,120 |
|
Less: Cash and cash equivalents |
|
|
30,020 |
|
|
23,070 |
|
Net Debt |
|
$ |
439,150 |
|
$ |
375,050 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260226886784/en/
VP, Investor Relations
(248) 631-5506
sherry.lauderback@trimas.com
Source: TriMas